User: Guest  Login
Title:

Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial.

Document type:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Article
Author(s):
Mehilli, J; Kastrati, A; Schulz, S; Früngel, S; Nekolla, SG; Moshage, W; Dotzer, F; Huber, K; Pache, J; Dirschinger, J; Seyfarth, M; Martinoff, S; Schwaiger, M; Schömig, A
Abstract:
BACKGROUND: The glycoprotein IIb/IIIa receptor inhibitor abciximab has improved the efficacy of primary percutaneous coronary interventions in patients with acute myocardial infarction. However, it is not known whether abciximab remains beneficial after adequate clopidogrel loading in patients with acute ST-segment-elevation myocardial infarction. METHODS AND RESULTS: A total of 800 patients with acute ST-segment-elevation myocardial infarction within 24 hours from symptom onset, all treated wit...     »
Journal title abbreviation:
Circulation
Year:
2009
Journal volume:
119
Journal issue:
14
Pages contribution:
1933-40
Language:
eng
Fulltext / DOI:
doi:10.1161/CIRCULATIONAHA.108.818617
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/19332467
Print-ISSN:
0009-7322
TUM Institution:
I. Medizinische Klinik und Poliklinik (Kardiologie); Institut für Radiologie; Klinik und Poliklinik für Nuklearmedizin
 BibTeX